These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 6327947)

  • 1. Tc-99m DMSA uptake by metastatic carcinoma of the prostate.
    Lamki L; Shearer R
    J Nucl Med; 1984 Jun; 25(6):733-4. PubMed ID: 6327947
    [No Abstract]   [Full Text] [Related]  

  • 2. Technetium-99m DMSA uptake by metastatic carcinoma of the prostate.
    Jeghers O; Puttemans N; Urbain D; Ham HR
    J Nucl Med; 1986 Jul; 27(7):1223-4. PubMed ID: 3014089
    [No Abstract]   [Full Text] [Related]  

  • 3. [Metastasis of hypernephroid carcinoma to the bones detected by 99mTc-dimercaptosuccinic acid].
    Smirnov IuN; Ivanov EV
    Med Radiol (Mosk); 1983 Jan; 28(1):76-7. PubMed ID: 6298556
    [No Abstract]   [Full Text] [Related]  

  • 4. Technetium-99m DMSA abnormal uptake by metastatic lesion of a renal cell carcinoma.
    Kosuda S; Hirono Y; Yoshinaga H; Saito K; Tamura K; Kubo A; Hashimoto S
    Clin Nucl Med; 1986 Jun; 11(6):432-3. PubMed ID: 3013485
    [No Abstract]   [Full Text] [Related]  

  • 5. Pentavalent technetium-99m-DMSA uptake in a patient having multiple myeloma without amyloidosis.
    Ohnishi T; Noguchi S; Murakami N; Tajiri J; Morita M; Tamaru M; Hoshi H; Watanabe K
    J Nucl Med; 1991 Sep; 32(9):1785-7. PubMed ID: 1652629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the tumor-seeking agent Tc-99m(V) dimercaptosuccinic acid and the renal imaging agent Tc-99m dimercaptosuccinic acid in humans.
    Ohta H; Ishii M; Yoshizumi M; Endo K; Sakahara H; Nakajima T; Yomoda I; Masuda H; Horiuchi K; Hata N
    Clin Nucl Med; 1985 Mar; 10(3):167-70. PubMed ID: 2985320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative radionuclide imaging of metastatic insular carcinoma of the thyroid: value of technetium-99m-(V)DMSA.
    Yen TC; King KL; Yang AH; Liu RS; Yeh SH
    J Nucl Med; 1996 Jan; 37(1):78-80. PubMed ID: 8544007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentavalent [99mTc]DMSA, [131I]MIBG, and [99mTc]MDP--an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid.
    Clarke SE; Lazarus CR; Wraight P; Sampson C; Maisey MN
    J Nucl Med; 1988 Jan; 29(1):33-8. PubMed ID: 2826723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tc-99m(V) DMSA imaging. A new approach to studying metastases from breast carcinoma.
    Kashyap R; Babbar A; Sahai I; Prakash R; Soni NL; Chauhan UP
    Clin Nucl Med; 1992 Feb; 17(2):119-22. PubMed ID: 1314148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technetium-99m(V)-DMSA in the imaging of medullary thyroid carcinoma.
    J Nucl Med; 1987 Feb; 28(2):252-3. PubMed ID: 3027281
    [No Abstract]   [Full Text] [Related]  

  • 11. Intraosseous hemangiomatosis: technetium-99m(V)dimercaptosuccinic acid and technetium-99m-hydroxymethylene diphosphonate imaging.
    Kobayashi H; Shigeno C; Sakahara H; Hosono M; Hosono M; Yao ZS; Endo K; Konishi J
    J Nucl Med; 1994 Sep; 35(9):1482-4. PubMed ID: 8071696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Visualization of subcutaneous metastases of hypernephroid cancer using 99mTc-dimercaptosuccinic acid].
    Smirnov IuN; Galil-Ogly GA; Pan'shin GA; Chazova NL
    Med Radiol (Mosk); 1989 Jun; 34(6):63-5. PubMed ID: 2544778
    [No Abstract]   [Full Text] [Related]  

  • 13. A new imaging agent for medullary carcinoma of the thyroid.
    Ohta H; Yamamoto K; Endo K; Mori T; Hamanaka D; Shimazu A; Ikekubo K; Makimoto K; Iida Y; Konishi J
    J Nucl Med; 1984 Mar; 25(3):323-5. PubMed ID: 6321700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using technetium-99m (V) dimercaptosuccinic acid to detect malignancies from single solid masses in the lungs.
    Kao CH; Wang SJ; Wey SP; Shen LH; Ting G; Yeh SH
    Eur J Nucl Med; 1992; 19(10):890-3. PubMed ID: 1333404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of Tc-99m (V) DMSA for chondrogenic tumors with positive Tc-99m HMDP uptake on bone scintigraphy.
    Kobayashi H; Kotoura Y; Hosono M; Sakahara H; Hosono M; Yao ZS; Tsuboyama T; Yamamuro T; Endo K; Konishi J
    Clin Nucl Med; 1995 Apr; 20(4):361-4. PubMed ID: 7788996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two 99mTc(V)-dimercaptosuccinic acid preparations.
    Jeghers O; Puttemans N; Urbain D; Lefebvre J; Ham HR
    Int J Rad Appl Instrum A; 1987; 38(1):13-8. PubMed ID: 3030963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Local findings of renal cell carcinoma on 99m-Tc-DMSA renal, 99m-Tc-MDP bone and 67-Ga-citrate scintigraphies].
    Kawamura J; Itoh H; Yoshida O; Fujita T; Fukunaga M; Morita R; Torizuka K
    Kaku Igaku; 1982 Apr; 19(3):357-68. PubMed ID: 6290720
    [No Abstract]   [Full Text] [Related]  

  • 18. 99mTc(V)DMSA quantitatively predicts 188Re(V)DMSA distribution in patients with prostate cancer metastatic to bone.
    Blower PJ; Kettle AG; O'Doherty MJ; Coakley AJ; Knapp FF
    Eur J Nucl Med; 2000 Sep; 27(9):1405-9. PubMed ID: 11007525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. False-positive technetium-99m DMSA renal imaging in two cases of malrotated kidney.
    Ueno K; Rikimaru S; Miyagi T; Mohri S
    Clin Nucl Med; 1985 Jul; 10(7):504-6. PubMed ID: 2992862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging of head and neck tumors with technetium(V)-99m DMSA. A new tumor-seeking agent.
    Ohta H; Endo K; Fujita T; Nakashima T; Sakahara H; Torizuka K; Shimizu Y; Ishii Y; Makimoto K; Hata N
    Clin Nucl Med; 1985 Dec; 10(12):855-60. PubMed ID: 3000682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.